Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial.
Ferrari V, Valcamonico F, Amoroso V, Simoncini E, Vassalli L, Marpicati P, Rangoni G, Grisanti S, Tiberio GA, Nodari F, Strina C, Marini G.
Ferrari V, et al.
Cancer Chemother Pharmacol. 2006 Jan;57(2):185-90. doi: 10.1007/s00280-005-0028-1. Epub 2005 Sep 3.
Cancer Chemother Pharmacol. 2006.
PMID: 16151811
Clinical Trial.